Adipocyte-specific tribbles pseudokinase 1 regulates plasma adiponectin and plasma lipids in mice

[1]  Stephen C. J. Parker,et al.  The Trans-Ancestral Genomic Architecture of Glycaemic Traits , 2020 .

[2]  G. Sweeney,et al.  Examining the Potential of Developing and Implementing Use of Adiponectin-Targeted Therapeutics for Metabolic and Cardiovascular Diseases , 2019, Front. Endocrinol..

[3]  D. Savage,et al.  What lipodystrophies teach us about the metabolic syndrome. , 2019, The Journal of clinical investigation.

[4]  R. Bauer,et al.  Trouble With Tribbles-1. , 2019, Arteriosclerosis, thrombosis, and vascular biology.

[5]  D. Rader,et al.  Myeloid Tribbles 1 induces early atherosclerosis via enhanced foam cell expansion , 2019, Science Advances.

[6]  H. Yanai,et al.  Beneficial Effects of Adiponectin on Glucose and Lipid Metabolism and Atherosclerotic Progression: Mechanisms and Perspectives , 2019, International journal of molecular sciences.

[7]  Gary D Bader,et al.  Pathway enrichment analysis and visualization of omics data using g:Profiler, GSEA, Cytoscape and EnrichmentMap , 2019, Nature Protocols.

[8]  P. Scherer,et al.  Acute loss of adipose tissue-derived adiponectin triggers immediate metabolic deterioration in mice , 2018, Diabetologia.

[9]  T. Horvath,et al.  Absence of ANGPTL4 in adipose tissue improves glucose tolerance and attenuates atherogenesis , 2018, JCI insight.

[10]  Pim van der Harst,et al.  Identification of 64 Novel Genetic Loci Provides an Expanded View on the Genetic Architecture of Coronary Artery Disease , 2017, Circulation research.

[11]  A. Tall.  Increasing Lipolysis and Reducing Atherosclerosis. , 2017, The New England journal of medicine.

[12]  P. Eyers,et al.  Tribbles in the 21st Century: The Evolving Roles of Tribbles Pseudokinases in Biology and Disease , 2017, Trends in cell biology.

[13]  Alexander E. Lopez,et al.  Inactivating Variants in ANGPTL4 and Risk of Coronary Artery Disease. , 2016, The New England journal of medicine.

[14]  D. Rader,et al.  Tribbles-1 regulates hepatic lipogenesis through posttranscriptional regulation of C/EBPα. , 2015, The Journal of clinical investigation.

[15]  D. Rader,et al.  Deletion of murine Arv1 results in a lean phenotype with increased energy expenditure , 2015, Nutrition & Diabetes.

[16]  R. Charnigo,et al.  Increasing Adipocyte Lipoprotein Lipase Improves Glucose Metabolism in High Fat Diet-induced Obesity* , 2015, The Journal of Biological Chemistry.

[17]  N. Møller,et al.  Dissecting adipose tissue lipolysis: molecular regulation and implications for metabolic disease. , 2014, Journal of molecular endocrinology.

[18]  M. Reilly,et al.  Differential Association of Plasma Angiopoietin-Like Proteins 3 and 4 With Lipid and Metabolic Traits , 2014, Arteriosclerosis, thrombosis, and vascular biology.

[19]  S. Kersten,et al.  Regulation of lipoprotein lipase by Angptl4 , 2014, Trends in Endocrinology & Metabolism.

[20]  S. Mandrup,et al.  Peroxisome Proliferator-Activated Receptor γ and C/EBPα Synergistically Activate Key Metabolic Adipocyte Genes by Assisted Loading , 2013, Molecular and Cellular Biology.

[21]  D. Kiortsis,et al.  Adiponectin and lipoprotein metabolism , 2013, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[22]  Tanya M. Teslovich,et al.  Discovery and refinement of loci associated with lipid levels , 2013, Nature Genetics.

[23]  M. Blüher.  Adipose tissue dysfunction contributes to obesity related metabolic diseases. , 2013, Best practice & research. Clinical endocrinology & metabolism.

[24]  L. Azadbakht,et al.  Epidemiologic Evidence on Serum Adiponectin Level and Lipid Profile , 2013, International journal of preventive medicine.

[25]  J. Danesh,et al.  Large-scale association analysis identifies new risk loci for coronary artery disease , 2012, Nature Genetics.

[26]  Karen L. Mohlke,et al.  Novel Loci for Adiponectin Levels and Their Influence on Type 2 Diabetes and Metabolic Traits: A Multi-Ethnic Meta-Analysis of 45,891 Individuals , 2012, PLoS genetics.

[27]  Simon C. Potter,et al.  Large-Scale Gene-Centric Analysis Identifies Novel Variants for Coronary Artery Disease , 2011, PLoS genetics.

[28]  Weijun Jin,et al.  Determination of lipoprotein lipase activity using a novel fluorescent lipase assay[S] , 2011, Journal of Lipid Research.

[29]  S. Akira,et al.  Trib1 is a lipid- and myocardial infarction-associated gene that regulates hepatic lipogenesis and VLDL production in mice. , 2010, The Journal of clinical investigation.

[30]  S. Blacklow,et al.  Differential ability of Tribbles family members to promote degradation of C/EBPalpha and induce acute myelogenous leukemia. , 2010, Blood.

[31]  Tanya M. Teslovich,et al.  Biological, Clinical, and Population Relevance of 95 Loci for Blood Lipids , 2010, Nature.

[32]  S. Akira,et al.  Control of Adipose Tissue Inflammation Through TRB1 , 2010, Diabetes.

[33]  N. Ehrhardt,et al.  Lipase maturation factor 1: structure and role in lipase folding and assembly , 2010, Current opinion in lipidology.

[34]  L. Groop,et al.  CCAAT/enhancer binding protein alpha (C/EBPalpha) in adipose tissue regulates genes in lipid and glucose metabolism and a genetic variation in C/EBPalpha is associated with serum levels of triglycerides. , 2008, The Journal of clinical endocrinology and metabolism.

[35]  M. Reilly,et al.  Adipose inflammation, insulin resistance, and cardiovascular disease. , 2008, JPEN. Journal of parenteral and enteral nutrition.

[36]  R. Collins,et al.  Newly identified loci that influence lipid concentrations and risk of coronary artery disease , 2008, Nature Genetics.

[37]  Dolores Corella,et al.  Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans , 2008, Nature Genetics.

[38]  A. Miyajima,et al.  TRB2, a Mouse Tribbles Ortholog, Suppresses Adipocyte Differentiation by Inhibiting AKT and C/EBPβ* , 2007, Journal of Biological Chemistry.

[39]  H. Sul,et al.  Regulation of lipolysis in adipocytes. , 2007, Annual review of nutrition.

[40]  T. Funahashi,et al.  Overexpression of adiponectin targeted to adipose tissue in transgenic mice: impaired adipocyte differentiation. , 2007, Endocrinology.

[41]  Bruce M. Spiegelman,et al.  Adipocytes as regulators of energy balance and glucose homeostasis , 2006, Nature.

[42]  S. Farmer.  Transcriptional control of adipocyte formation. , 2006, Cell metabolism.

[43]  Herbert Tilg,et al.  Adipocytokines: mediators linking adipose tissue, inflammation and immunity , 2006, Nature Reviews Immunology.

[44]  C. Fraser,et al.  Transgenic angiopoietin-like (angptl)4 overexpression and targeted disruption of angptl4 and angptl3: regulation of triglyceride metabolism. , 2005, Endocrinology.

[45]  D. Rader,et al.  Determining hepatic triglyceride production in mice: comparison of poloxamer 407 with Triton WR-1339 Published, JLR Papers in Press, July 1, 2005. DOI 10.1194/jlr.D500019-JLR200 , 2005, Journal of Lipid Research.

[46]  B. Richelsen,et al.  Adiponectin: action, regulation and association to insulin sensitivity , 2005, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[47]  Cynthia J. Girman,et al.  Plasma adiponectin levels and risk of myocardial infarction in men. , 2004, JAMA.

[48]  Yu Wang,et al.  The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice. , 2003, The Journal of clinical investigation.

[49]  Huijun Sun,et al.  Overexpression of Lipoprotein Lipase in Transgenic Rabbits Inhibits Diet-induced Hypercholesterolemia and Atherosclerosis* , 2001, The Journal of Biological Chemistry.

[50]  P. Scherer,et al.  The adipocyte-secreted protein Acrp30 enhances hepatic insulin action , 2001, Nature Medicine.

[51]  I. J. Goldberg,et al.  Lipoprotein lipase: physiology, biochemistry, and molecular biology. , 2001, Frontiers in bioscience : a journal and virtual library.

[52]  P. Rørth,et al.  The level of C/EBP protein is critical for cell migration during Drosophila oogenesis and is tightly controlled by regulated degradation. , 2000, Molecular cell.

[53]  Y. Yazaki,et al.  Suppression of diet-induced atherosclerosis in low density lipoprotein receptor knockout mice overexpressing lipoprotein lipase. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[54]  S. Eisenberg,et al.  Lipolysis exposes unreactive endogenous apolipoprotein E-3 in human and rat plasma very low density lipoprotein. , 1991, The Journal of clinical investigation.

[55]  J. Ntambi,et al.  Differentiation-induced gene expression in 3T3-L1 preadipocytes: CCAAT/enhancer binding protein interacts with and activates the promoters of two adipocyte-specific genes. , 1989, Genes & development.

[56]  A. Chait,et al.  Modification of low density lipoprotein by lipoprotein lipase or hepatic lipase induces enhanced uptake and cholesterol accumulation in cells. , 1988, The Journal of biological chemistry.

[57]  Alex P. Reiner,et al.  Loss-of-Function Mutations in APOC 3 , Triglycerides , and Coronary Disease , 2014 .

[58]  L. Sechi,et al.  Plasma adiponectin is decreased in nonalcoholic fatty liver disease. , 2005, European journal of endocrinology.

[59]  Y. Deshaies,et al.  A transgenic mouse with a deletion in the collagenous domain of adiponectin displays elevated circulating adiponectin and improved insulin sensitivity. , 2004, Endocrinology.